In re Flonase Antitrust Litigation

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

• finding factor six weighed in favor of the requested fee award where “class counsel spent more than 40,000 hours over the course of more than four years litigating th[e] case”
• approving plan of allocation as fair, reasonable, and adequate where, in antitrust action against brand name drug manufacturer, each class member receives their pro rata share of the net settlement fund, based on their share of qualifying purchases of the brand name drug
• approving plan of allocation as fair, reasonable, and adequate where, in antitrust action against brand name drug manufacturer, each class member receives their pro rata share of the net settlement fund, based on their share of qualifying purchases of the brand name drug
• “Antitrust class actions are particularly complex to litigate and therefore quite expensive.”
• “Antitrust class actions are particularly complex to litigate and therefore quite expensive.”

Source: CourtListener parenthetical corpus (CC0).

Cited by

1 case in this archive cites this case.

• Jackson v. Wells Fargo Bank, N.A.
  W.D. Pennsylvania· 2015-09-30· cited 13×

Cites

25 cases in this archive are cited by this case; the 20 most cited are listed.

• In Re General Motors Corporation Pick-Up Truck Fuel Tank Products Liability Litigation. Jack French, Robert M. West, Charles E. Merritt, Gary Blades, Dawn and Tracey Best, Gary and Jackie Barnes, Betty Marteny, John and Mary Southands, Edmund Berning, Dale W. Plummer, Edmund and Anneta Casey, John a
  Third Circuit· 1995-04-17· cited 850×
• In Re: The Prudential Insurance Company Of America Sales Practices Litigation
  Third Circuit· 1998-07-23· cited 840×
• In Re: Cendant Corporation Litigation
  Third Circuit· 1992-02-11· cited 465×
• Girsh v. Jepson
  Third Circuit· 1975-07-25· cited 427×
• Unnamed case
  Third Circuit· 2000-07-27· cited 267×
• In Re Rite Aid Corporation Securities Litigation Class Member/objector Walter Kaufmann
  Third Circuit· 2005-02-25· cited 247×
• In Re Pet Food Products Liability Litigation
  Third Circuit· 2010-12-16· cited 154×
• In Re Diet Drugs
  Third Circuit· 2009-10-08· cited 109×
• Karcich v. Stuart
  E.D. Pennsylvania· 2000-05-09· cited 104×
• Zenith Laboratories, Inc., on Behalf of Itself and All Others Similarly Situated v. Carter-Wallace, Inc
  Third Circuit· 1976-02-10· cited 96×
• Cullen v. Whitman Medical Corp.
  E.D. Pennsylvania· 2000-10-03· cited 77×
• Reibstein v. RITE AID CORPORATION
  E.D. Pennsylvania· 2011-01-18· cited 45×
• United States Football League v. National Football League
  S.D. New York· 1986-10-02· cited 43×
• In Re at & T Corporation, Securities Litigation. Marion Washburn and William A. Hoffmann, Iii, Class Members and Objectors, at No. 05-2727. Jacquelynn D. Frame and Donald J. Frame, Class Members and Objectors, at No. 05-2728
  Third Circuit· 2006-07-20· cited 42×
• In Re K-Dur Antitrust Litigation
  Third Circuit· 2012-07-16· cited 32×
• In re Southern Ohio Correctional Facility
  S.D. Ohio· 1997-07-24· cited 27×
• In re U.S. Bioscience Securities Litigation
  E.D. Pennsylvania· 1994-05-27· cited 26×
• In Re Linerboard Antitrust Litigation
  E.D. Pennsylvania· 2003-12-12· cited 25×
• McCoy v. Health Net, Inc.
  D. New Jersey· 2008-08-08· cited 24×
• In Re Motorsports Merchandise Antitrust Litigation
  N.D. Georgia· 2000-09-14· cited 21×